Cigna Corp
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government … Read more
Cigna Corp (CI) - Net Assets
Latest net assets as of September 2025: $42.01 Billion USD
Based on the latest financial reports, Cigna Corp (CI) has net assets worth $42.01 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($157.92 Billion) and total liabilities ($115.91 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $42.01 Billion |
| % of Total Assets | 26.6% |
| Annual Growth Rate | 6.34% |
| 5-Year Change | -18.15% |
| 10-Year Change | 240.49% |
| Growth Volatility | 34.08 |
Cigna Corp - Net Assets Trend (1985–2024)
This chart illustrates how Cigna Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cigna Corp (1985–2024)
The table below shows the annual net assets of Cigna Corp from 1985 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $41.24 Billion | -11.02% |
| 2023-12-31 | $46.35 Billion | +3.22% |
| 2022-12-31 | $44.90 Billion | -4.83% |
| 2021-12-31 | $47.18 Billion | -6.35% |
| 2020-12-31 | $50.39 Billion | +11.03% |
| 2019-12-31 | $45.38 Billion | +10.49% |
| 2018-12-31 | $41.07 Billion | +197.84% |
| 2017-12-31 | $13.79 Billion | +0.04% |
| 2016-12-31 | $13.79 Billion | +13.80% |
| 2015-12-31 | $12.11 Billion | +11.61% |
| 2014-12-31 | $10.85 Billion | +1.65% |
| 2013-12-31 | $10.68 Billion | +8.03% |
| 2012-12-31 | $9.88 Billion | +18.44% |
| 2011-12-31 | $8.34 Billion | +25.23% |
| 2010-12-31 | $6.66 Billion | +22.73% |
| 2009-12-31 | $5.43 Billion | +51.14% |
| 2008-12-31 | $3.59 Billion | -24.35% |
| 2007-12-31 | $4.75 Billion | +9.65% |
| 2006-12-31 | $4.33 Billion | -19.22% |
| 2005-12-31 | $5.36 Billion | +3.02% |
| 2004-12-31 | $5.20 Billion | +15.14% |
| 2003-12-31 | $4.52 Billion | +16.86% |
| 2002-12-31 | $3.87 Billion | -23.50% |
| 2001-12-31 | $5.05 Billion | -6.61% |
| 2000-12-31 | $5.41 Billion | -11.97% |
| 1999-12-31 | $6.15 Billion | -25.71% |
| 1998-12-31 | $8.28 Billion | +4.35% |
| 1997-12-31 | $7.93 Billion | +10.04% |
| 1996-12-31 | $7.21 Billion | +0.71% |
| 1995-12-31 | $7.16 Billion | +23.16% |
| 1994-12-31 | $5.81 Billion | -11.62% |
| 1993-12-31 | $6.58 Billion | +14.47% |
| 1992-12-31 | $5.74 Billion | -2.03% |
| 1991-12-31 | $5.86 Billion | +11.85% |
| 1990-12-31 | $5.24 Billion | -5.04% |
| 1989-12-31 | $5.52 Billion | +5.39% |
| 1988-12-31 | $5.24 Billion | +5.32% |
| 1987-12-31 | $4.97 Billion | +7.52% |
| 1986-12-31 | $4.62 Billion | +23.20% |
| 1985-12-31 | $3.75 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cigna Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2186.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $43.52 Billion | 106.06% |
| Common Stock | $4.00 Million | 0.01% |
| Other Comprehensive Income | $-2.34 Billion | -5.71% |
| Total Equity | $41.03 Billion | 100.00% |
Cigna Corp Competitors by Market Cap
The table below lists competitors of Cigna Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
GSK plc
PINK:GLAXF
|
$71.18 Billion |
|
American Electric Power Co Inc
NASDAQ:AEP
|
$71.56 Billion |
|
CN YANGT.PWR GDR REG S/A
F:CYZB
|
$71.71 Billion |
|
Marvell Technology Group Ltd
NASDAQ:MRVL
|
$71.74 Billion |
|
UniCredit SpA
PINK:UNCFF
|
$70.92 Billion |
|
Illinois Tool Works Inc
NYSE:ITW
|
$70.30 Billion |
|
BP p.l.c
PINK:BPAQF
|
$69.85 Billion |
|
Transdigm Group Incorporated
NYSE:TDG
|
$69.26 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cigna Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 46,223,000,000 to 41,033,000,000, a change of -5,190,000,000 (-11.2%).
- Net income of 3,434,000,000 contributed positively to equity growth.
- Dividend payments of 1,567,000,000 reduced retained earnings.
- Share repurchases of 7,034,000,000 reduced equity.
- New share issuances of 305,000,000 increased equity.
- Other comprehensive income decreased equity by 477,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $3.43 Billion | +8.37% |
| Dividends Paid | $1.57 Billion | -3.82% |
| Share Repurchases | $7.03 Billion | -17.14% |
| Share Issuances | $305.00 Million | +0.74% |
| Other Comprehensive Income | $-477.00 Million | -1.16% |
| Other Changes | $149.00 Million | +0.36% |
| Total Change | $- | -11.23% |
Book Value vs Market Value Analysis
This analysis compares Cigna Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.82x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 43.40x to 1.82x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $6.07 | $263.47 | x |
| 1986-12-31 | $6.73 | $263.47 | x |
| 1987-12-31 | $6.97 | $263.47 | x |
| 1988-12-31 | $7.39 | $263.47 | x |
| 1989-12-31 | $7.80 | $263.47 | x |
| 1990-12-31 | $7.67 | $263.47 | x |
| 1991-12-31 | $9.09 | $263.47 | x |
| 1992-12-31 | $8.92 | $263.47 | x |
| 1993-12-31 | $10.20 | $263.47 | x |
| 1994-12-31 | $8.90 | $263.47 | x |
| 1995-12-31 | $10.78 | $263.47 | x |
| 1996-12-31 | $10.50 | $263.47 | x |
| 1997-12-31 | $11.87 | $263.47 | x |
| 1998-12-31 | $12.92 | $263.47 | x |
| 1999-12-31 | $10.39 | $263.47 | x |
| 2000-12-31 | $11.15 | $263.47 | x |
| 2001-12-31 | $11.18 | $263.47 | x |
| 2002-12-31 | $9.14 | $263.47 | x |
| 2003-12-31 | $10.73 | $263.47 | x |
| 2004-12-31 | $12.58 | $263.47 | x |
| 2005-12-31 | $13.77 | $263.47 | x |
| 2006-12-31 | $12.86 | $263.47 | x |
| 2007-12-31 | $16.77 | $263.47 | x |
| 2008-12-31 | $12.88 | $263.47 | x |
| 2009-12-31 | $19.67 | $263.47 | x |
| 2010-12-31 | $24.14 | $263.47 | x |
| 2011-12-31 | $30.42 | $263.47 | x |
| 2012-12-31 | $33.74 | $263.47 | x |
| 2013-12-31 | $37.12 | $263.47 | x |
| 2014-12-31 | $40.11 | $263.47 | x |
| 2015-12-31 | $46.18 | $263.47 | x |
| 2016-12-31 | $52.85 | $263.47 | x |
| 2017-12-31 | $56.30 | $263.47 | x |
| 2018-12-31 | $166.34 | $263.47 | x |
| 2019-12-31 | $119.37 | $263.47 | x |
| 2020-12-31 | $136.60 | $263.47 | x |
| 2021-12-31 | $138.17 | $263.47 | x |
| 2022-12-31 | $143.33 | $263.47 | x |
| 2023-12-31 | $155.69 | $263.47 | x |
| 2024-12-31 | $144.88 | $263.47 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cigna Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 8.37%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.39%
- • Asset Turnover: 1.59x
- • Equity Multiplier: 3.80x
- Recent ROE (8.37%) is below the historical average (13.02%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | -22.77% | 0.00% | 0.00x | 11.92x | $-1.23 Billion |
| 1986 | 11.57% | 0.00% | 0.00x | 10.81x | $72.40 Million |
| 1987 | 13.79% | 0.00% | 0.00x | 10.76x | $188.30 Million |
| 1988 | 9.02% | 0.00% | 0.00x | 10.66x | $-51.56 Million |
| 1989 | 10.18% | 4.89% | 0.20x | 10.47x | $10.00 Million |
| 1990 | 6.30% | 2.36% | 0.22x | 12.15x | $-194.20 Million |
| 1991 | 7.66% | 3.14% | 0.21x | 11.38x | $-137.30 Million |
| 1992 | 5.41% | 2.23% | 0.20x | 12.16x | $-263.40 Million |
| 1993 | 3.56% | 1.71% | 0.16x | 12.92x | $-423.50 Million |
| 1994 | 9.53% | 3.01% | 0.21x | 14.82x | $-27.10 Million |
| 1995 | 2.95% | 1.11% | 0.20x | 13.40x | $-504.70 Million |
| 1996 | 14.65% | 5.57% | 0.19x | 13.73x | $335.20 Million |
| 1997 | 13.69% | 9.22% | 0.11x | 13.64x | $292.80 Million |
| 1998 | 15.61% | 7.32% | 0.15x | 13.85x | $464.30 Million |
| 1999 | 28.85% | 9.47% | 0.20x | 15.50x | $1.16 Billion |
| 2000 | 17.46% | 4.84% | 0.21x | 17.57x | $403.70 Million |
| 2001 | 18.58% | 5.05% | 0.20x | 18.12x | $433.50 Million |
| 2002 | -11.56% | -2.31% | 0.22x | 23.00x | $-833.70 Million |
| 2003 | 13.99% | 3.36% | 0.21x | 20.13x | $180.10 Million |
| 2004 | 27.64% | 7.91% | 0.22x | 15.58x | $917.70 Million |
| 2005 | 30.32% | 9.74% | 0.37x | 8.37x | $1.09 Billion |
| 2006 | 26.67% | 6.98% | 0.39x | 9.79x | $722.00 Million |
| 2007 | 23.48% | 6.33% | 0.44x | 8.44x | $640.20 Million |
| 2008 | 8.13% | 1.53% | 0.46x | 11.53x | $-67.20 Million |
| 2009 | 24.04% | 7.07% | 0.43x | 7.94x | $760.30 Million |
| 2010 | 19.25% | 6.07% | 0.46x | 6.87x | $614.50 Million |
| 2011 | 15.10% | 5.82% | 0.42x | 6.12x | $425.60 Million |
| 2012 | 16.61% | 5.57% | 0.54x | 5.50x | $646.10 Million |
| 2013 | 13.97% | 4.56% | 0.60x | 5.14x | $419.30 Million |
| 2014 | 19.51% | 6.02% | 0.62x | 5.19x | $1.02 Billion |
| 2015 | 17.40% | 5.53% | 0.66x | 4.74x | $890.50 Million |
| 2016 | 13.60% | 4.69% | 0.67x | 4.33x | $494.70 Million |
| 2017 | 16.29% | 5.35% | 0.68x | 4.50x | $863.50 Million |
| 2018 | 6.43% | 5.42% | 0.32x | 3.73x | $-1.47 Billion |
| 2019 | 11.26% | 3.32% | 0.99x | 3.44x | $570.20 Million |
| 2020 | 16.81% | 5.27% | 1.03x | 3.09x | $3.43 Billion |
| 2021 | 11.40% | 3.08% | 1.12x | 3.29x | $658.80 Million |
| 2022 | 14.94% | 3.71% | 1.25x | 3.21x | $2.22 Billion |
| 2023 | 11.17% | 2.64% | 1.28x | 3.30x | $541.70 Million |
| 2024 | 8.37% | 1.39% | 1.59x | 3.80x | $-669.30 Million |
Industry Comparison
This section compares Cigna Corp's net assets metrics with peer companies in the Healthcare Plans industry.
Industry Context
- Industry: Healthcare Plans
- Average net assets among peers: $4,700,894,723
- Average return on equity (ROE) among peers: -5.70%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cigna Corp (CI) | $42.01 Billion | -22.77% | 2.76x | $71.15 Billion |
| Alignment Healthcare LLC (ALHC) | $239.30 Million | -62.49% | 1.65x | $3.04 Billion |
| Clover Health Investments Corp (CLOV) | $-17.63K | 0.00% | 0.00x | $788.86 Million |
| Centene Corp (CNC) | $326.42 Million | -13.37% | 1.74x | $17.10 Billion |
| CarePayment Technologies Inc (CPYT) | $6.95 Million | -32.50% | 0.49x | $2.47K |
| CVS Health Corp (CVS) | $1.10 Billion | 19.07% | 0.64x | $94.98 Billion |
| Elevance Health Inc (ELV) | $23.81 Billion | 12.12% | 1.15x | $63.54 Billion |
| Humana Inc (HUM) | $16.10 Billion | 18.21% | 1.75x | $20.50 Billion |
| Interact Holdings Group Inc (IHGP) | $-1.46 Million | 0.00% | 0.00x | $335.63 |
| Molina Healthcare Inc (MOH) | $719.06 Million | 7.64% | 1.10x | $6.97 Billion |